<html>
<head>PUBMED IDs for CYP46A1</head>
<body bgcolor='#C5F0F2'><h1>CYP46A1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15016763/'>A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids.</a> March 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15148325/'>Differential expression of cholesterol hydroxylases in Alzheimer's disease.</a> May 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15649702/'>ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.</a> January 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16258842/'>CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.</a> November 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16255374/'>[Cholesterol and Alzheimer's disease].</a> November 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16321981/'>Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes.</a> December 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16340204/'>Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.</a> December 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16734927/'>Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.</a> June 1  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16973241/'>Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.</a> September 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17532301/'>Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway.</a> May 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18445135/'>Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors.</a> May 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18690964/'>Statin-like drugs for the treatment of brain cholesterol loss in Alzheimer's disease.</a> August 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18792811/'>Modifications of the expression of genes involved in cerebral cholesterol metabolism in the rat following chronic ingestion of depleted uranium.</a> September 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19059217/'>Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors.</a> December 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19212968/'>Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study.</a> August 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19286353/'>CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.</a> June 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19474457/'>The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.</a> March 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19474452/'>Perioperative genomic profiles using structure-specific oligonucleotide probes.</a> December 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19553612/'>Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.</a> December 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19654569/'>Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.</a> March 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20096088/'>Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription.</a> May 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20693622/'>CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease.</a> February 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20930312/'>Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.</a> May 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21162674/'>Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.</a> October 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21162657/'>Molecular epidemiological analysis of mitochondrial DNA12SrRNA A1555G, GJB2, and SLC26A4 mutations in sporadic outpatients with nonsyndromic sensorineural hearing loss in China.</a> June 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21531213/'>24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.</a> January 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21576599/'>Cholesterol 25-hydroxylation activity of CYP3A.</a> November 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21576590/'>NRAS-mutant melanoma: response to chemotherapy.</a> August 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21576551/'>Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita.</a> November 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22060190/'>Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter.</a> February 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22185844/'>Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.</a> October 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528464/'>An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.</a> April 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22693257/'>Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22977134/'>Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration.</a> January 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23070465/'>CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.</a> February 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23326422/'>Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux.</a> July 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23792195/'>CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25084760/'>Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.</a> March 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26239836/'>Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways.</a> May 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26239826/'>Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA.</a> March 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26358780/'>Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.</a> August 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26912634/'>CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.</a> July 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27162448/'>Polymorphism of CYP46A1 and PPARγ2 Genes in Risk Prediction of Primary Open Angle Glaucoma Among North Indian Population.</a> March 23  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28190002/'>Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.</a> February 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28298860/'>Association of angiotensin-converting enzyme, CYP46A1 genes polymorphism with senile cataract.</a> March 17  2017<br></body></html>
